Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn with persistent pulmonary hypertension

Pediatric Research

Volumn 44, Issue 6, 1998, Pages 831-837

  Dukarm, Robert C ^a   Morin III, Frederick C ^a   Russell, James A ^a   Steinhorn, Robin H ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HEMODYNAMICS; LAMB; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0031725551     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199812000-00002     Document Type: Article

References (42)

1. Hageman JR, Adams MA, Gardner TH 1984 Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management. Am J Dis Child 138:592-595
2. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, Delemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH 1997 Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 131:55-62
3. Roberts JD, Fineman J, Morin III FC, Shaul PW, Rimar S, Schreiber MD, Polin RA, Thusu KG, Zayek M, Zwass MS, Zellers TM, Wylam ME, Gross I, Zapol WM, Heymann MA 1997 Inhaled nitric oxide gas improves oxygenation in PPHN. N Engl J Med 336:605-610
4. Neonatal Inhaled Nitric Oxide Study Group 1997 Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597-604
5. Barefield ES, Karle VA, Philips III JB, Carlo WA 1996 Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 129:279-286
6. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA 1994 Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 124:302-308
7. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fineman JR, Morin III FC 1994 Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 94:715-718
8. Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin III FC 1997 Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130:417-422
9. Beavo JA 1995 Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748
10. Braner DAV, Fineman JR, Chang R, Soifer SJ 1993 M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 264:H252-H258
11. Ichinose F, Adrie C, Hurford WE, Zapol WM 1995 Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J Appl Physiol 78:1288-1295
12. McMahon TJ, Ignarro LJ, Kadowitz PJ 1993 Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74:1704-1711
13. Skimming JW, DeMarco VG, Kadowitz PJ, Cassin S 1996 Effects of zaprinast and dissolved nitric oxide on the pulmonary circulation of fetal sheep. Pediatr Res 39:223-228
14. Thusu KG, Morin III FC, Russell JA, Steinhorn RH 1995 The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Resp Crit Care Med 152:1605-1610
15. Cohen Ah, Hanson K, Morris K, Fouty B, McMurtry IF, Clarke W, Rodman DM 1996 Inhibition of cyclic 3′-5′-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats. J Clin Invest 97:172-179
16. Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH 1995 Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol 269:H473-H479
17. Ziegler JW, Ivy DD, Kinsella JP, Clarke WR, Abman SH 1994 Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med 157:1104-1110
18. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH 1995 Dipyridamole augmentation of response to nitric oxide. Lancet 346:647-648
19. Morin III FC, Eagan EA 1989 The effect of closing the ductus arteriosus on the pulmonary circulation of the fetal sheep. J Dev Physiol 11:245-250
20. Steinhorn RH, Russell JA, Morin III F 1995 Disruption of cyclic GMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 268:H1483-H1489
21. Weibel ER 1991 Design of airways and blood vessels considered as branching trees. In: Crystal RG and West JB eds, The Lung: Scientific Foundations. Raven Press, Ltd, New York, pp 711
22. Johns R, Linder J, Peach M 1989 Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res 65:1508-1515
23. Nielsen-Kudsk F, Pedersen AK 1979 Pharmacokinetics of dipyridamole. Acta Pharmacol Toxicol 44:391-399
24. Mahony C, Wolfram KM, Cocchetto DM, Bjornsson TD 1982 Dipyridamole kinetics. Clin Pharmacol Ther 31:330-338
25. Christou H, Adatia I, VanMarter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, Kourembanas S 1997 Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 130:603-611
26. Crawley DE, Zhao L, Giembycz MA, Liu S, Barnes PJ, Winter RJD, Evans TW 1992 Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol 263:L325-L332
27. Thomas MK, Francis SH, Corbine JD 1990 Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem 265:14964-14970
28. Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, Magnussen H 1994 Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 266:L536-L543
29. Lugnier C, Schoeffter P, Lebec A, Strouthou E, Stoclet JC 1986 Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine, and rat aorta. Biochem Pharmacol 35:1743-1751
30. Fitzgerald GA 1987 Drug therapy: dipyridamole. N Engl J Med 316:1247-1257
31. Thompson WJ 1991 Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol Ther 51:13-33
32. Masotti G, Poggesi L, Galanti G, Semen GGN 1979 Stimulation of prostacyclin by dipyridamole. Lancet 1:1412-1414
33. Van de Velde VJS, Blut H, Weisenberger H, Herman AG 1981 Dipyridamole stimulates prostacyclin production in isolated rat aortic tissue. Arch Int Pharmacodyn Ther 256:327-328
34. Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, Morin III FC 1997 Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol 272:L1005-L1012
35. Rosenkrantz JG, Lynch FP, Vogel JHK 1972 Hypoxic pulmonary hypertension: its modification by dipyridamole. J Surg Res 12:330-333
36. Mlczoch J, Weir EK, Grover RF 1977 Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated. Can J Physiol Pharmacol 55:447-451
37. Hanson KA, Abman SH, Clarke WR 1996 Elevation of pulmonary PDE5-specific activity in an experimental fetal ovine perinatal pulmonary hypertension model. Pediatr Res 39:334A
38. Sanchez LS, Bloch KD, Morin III FC, Steinhorn RH 1997 Phosphodiesterase 5 enzyme activity and gene expression are altered in newborn lambs with persistent pulmonary hypertension. Pediatr Res 41:267A
39. Crutchley DJ, Ryan US, Ryan JW 1980 Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. J Clin Invest 66:29-35
40. Konduri GG, Woodard LL, Mukhopadhyay A, Deshmukh DR 1992 Adenosine is a pulmonary vasodilator in newborn lambs. Am Rev Respir Dis 146:670-676
41. Skimming JW, DeMarco VG, Cassin S 1997 Effects of dipyridamole and adenosine infusions on ovine pulmonary and systemic circulations. Am J Physiol H921-H926
42. Wild LM, Nickerson PA, Morin III FC 1989 Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25:251-257